| Schedule of Common Shares Issued |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
$ millions, except number of shares, for the three months ended |
|
|
|
|
|
|
|
|
|
|
2022
Oct. 31 |
|
|
2022 Jan. 31 |
|
|
|
|
|
|
|
|
|
|
|
|
Number of shares |
|
|
|
Amount |
|
|
|
Number of shares |
|
|
|
Amount |
|
Balance at beginning of period |
|
|
|
|
|
|
|
|
|
|
904,691,173 |
|
|
$ |
14,643 |
|
|
|
901,655,952 |
|
|
$ |
14,351 |
|
Issuance pursuant to: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Equity-settled share-based compensation plans (2) |
|
|
|
|
|
|
|
|
|
|
48,754 |
|
|
|
3 |
|
|
|
1,076,678 |
|
|
|
59 |
|
Shareholder investment plan (3) |
|
|
|
|
|
|
|
|
|
|
669,608 |
|
|
|
40 |
|
|
|
453,030 |
|
|
|
36 |
|
Employee share purchase plan |
|
|
|
|
|
|
|
|
|
|
593,192 |
|
|
|
38 |
|
|
|
532,740 |
|
|
|
40 |
|
| |
|
|
|
|
|
|
|
|
|
|
906,002,727 |
|
|
$ |
14,724 |
|
|
|
903,718,400 |
|
|
$ |
14,486 |
|
Purchase of common shares for
cancellation |
|
|
|
|
|
|
|
|
|
|
– |
|
|
|
– |
|
|
|
(1,800,000 |
) |
|
|
(29 |
) |
Treasury shares |
|
|
|
|
|
|
|
|
|
|
37,370 |
|
|
|
2 |
|
|
|
4,230 |
|
|
|
– |
|
Balance at end of period |
|
|
|
|
|
|
|
|
|
|
906,040,097 |
|
|
$ |
14,726 |
|
|
|
901,922,630 |
|
|
$ |
14,457 |
|
| (1) |
On April 7, 2022, CIBC shareholders approved a share split (Share Split) of CIBC’s issued and outstanding common shares. Each shareholder of record at the close of business on May 6, 2022 (Record Date) received one additional share on May 13, 2022 (Payment Date) for every one share held on the Record Date. All common share numbers and per common share amounts have been adjusted to reflect the Share Split as if it was retroactively applied to the beginning of 2022. |
| (2) |
Includes the settlement of contingent consideration related to prior acquisitions. |
| (3) |
Commencing with the dividends paid on January 27, 2023, the participants in the Dividend Reinvestment Option and Stock Dividend Option of the Shareholder Investment Plan received a 2% discount from average market price on dividends reinvested in additional common shares issued from Treasury. |
|
| Schedule of Regulatory Capital and Ratios |
Regulatory capital, leverage and total loss absorbing capacity ratios Our capital, leverage and total loss absorbing capacity (TLAC) ratios are presented in the table below:
|
|
|
|
|
|
|
|
|
|
|
$ millions, as at |
|
|
|
|
|
|
2022
Oct. 31 |
|
Common Equity Tier 1 (CET1) capital (1) |
|
|
|
|
36,649 |
|
|
$ |
37,005 |
|
| |
|
A |
|
|
|
|
|
|
41,946 |
|
| |
|
|
|
|
|
|
|
|
48,263 |
|
| Total risk-weighted assets (RWA) |
|
B |
|
|
|
|
|
|
315,634 |
|
| CET1 ratio |
|
|
|
|
|
|
|
|
11.7 |
% |
| Tier 1 capital ratio |
|
|
|
|
|
|
|
|
13.3 |
% |
| Total capital ratio |
|
|
|
|
|
|
|
|
15.3 |
% |
Leverage ratio exposure (2) |
|
C |
|
|
|
|
|
$ |
961,791 |
|
| Leverage ratio |
|
A/C |
|
|
|
|
|
|
4.4 |
% |
| TLAC available |
|
D |
|
|
|
|
|
$ |
95,136 |
|
| TLAC ratio |
|
D/B |
|
|
|
|
|
|
30.1 |
% |
| TLAC leverage ratio |
|
D/C |
|
|
|
|
|
|
9.9 |
% |
| (1) |
The 2022 results included the impact of the ECL transitional arrangement announced by OSFI on March 27, 2020. The transitional arrangement resulted in a portion of ECL allowances that would otherwise be included in Tier 2 capital qualifying for inclusion in CET1 capital. Starting November 1, 2022, the ECL transitional arrangement was no longer applicable. |
| (2) |
The temporary exclusion of Central bank reserves from the leverage ratio exposure measure in response to the onset of the COVID-19 pandemic remains applicable until April 1, 2023. |
|